We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Risk assessments on the investigation into the risk to human health of avian influenza (influenza A H5N1) in England.
Notifications of scarlet fever disease in England and data from invasive group A streptococci (iGAS) surveillance.
Reports on the surveillance of mortality during periods of heatwave.
Analysis and learning from radiotherapy and near miss data reported voluntarily by UK radiotherapy providers and the relevant reporting authorities.
How the actual number of deaths in England compare to expected numbers for each week.
Information on chlamydia testing and diagnoses in 15 to 24 year olds in England by demographic characteristics and geographical region.
Information on STI diagnoses and sexual health services provided in England by demographic characteristics and geographical region.
Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital and community settings in England during the 2023 to 2024 season.
National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.
Epidemiological, microbiological and food chain investigation summary about an outbreak of Shiga toxin-producing Escherichia coli (STEC) O145.
Modelled proportion of the population (prevalence) in England and Scotland currently infected with SARS-CoV-2 (COVID-19), incidence of new infections, the infection hospitalisation rate (IHR) and the infection fatality risk …
UKHSA publishes overviews each year of influenza surveillance results from the winter period.
Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.
Uptake of the seasonal influenza vaccine in frontline healthcare workers during the 2023 to 2024 influenza vaccination programme in England.
Report on the uptake of influenza vaccine in GP patients during the 2023 to 2024 influenza vaccination programme in England.
Analysis of data on non-travel associated shigella infections in England.
Evaluation of the ninth year of the shingles vaccination programme in England: financial year 2022 to 2023.
This rapid mapping review identifies and categorises evidence on the health equity impacts of climate change in the UK.
This rapid review summarises available evidence on infectious disease transmission risk in communal accommodation settings.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).